News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bristol-Myers Squibb Company Continues Excellent Financial Performance Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
October 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY): Reports Broad-Based Net Sales Growth of 14% from Continuing Operations
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
·
2 min read
·
Tristan Manalac
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient on Yorvipath
October 21, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives
October 17, 2025
·
73 min read
·
BioSpace Editorial Staff
